JP2022536913A5 - - Google Patents
Info
- Publication number
- JP2022536913A5 JP2022536913A5 JP2021573799A JP2021573799A JP2022536913A5 JP 2022536913 A5 JP2022536913 A5 JP 2022536913A5 JP 2021573799 A JP2021573799 A JP 2021573799A JP 2021573799 A JP2021573799 A JP 2021573799A JP 2022536913 A5 JP2022536913 A5 JP 2022536913A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- residues
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025078387A JP2025121997A (ja) | 2019-06-14 | 2025-05-09 | Ｐｄ－１に対する抗体およびその使用方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962861638P | 2019-06-14 | 2019-06-14 | |
| US62/861,638 | 2019-06-14 | ||
| US201962884473P | 2019-08-08 | 2019-08-08 | |
| US62/884,473 | 2019-08-08 | ||
| PCT/US2020/037791 WO2020252478A2 (en) | 2019-06-14 | 2020-06-15 | Antibodies against pd-1 and methods of use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025078387A Division JP2025121997A (ja) | 2019-06-14 | 2025-05-09 | Ｐｄ－１に対する抗体およびその使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022536913A JP2022536913A (ja) | 2022-08-22 |
| JP2022536913A5 true JP2022536913A5 (https=) | 2023-06-20 |
| JP7680968B2 JP7680968B2 (ja) | 2025-05-21 |
Family
ID=73782142
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021573799A Active JP7680968B2 (ja) | 2019-06-14 | 2020-06-15 | Ｐｄ－１に対する抗体およびその使用方法 |
| JP2025078387A Pending JP2025121997A (ja) | 2019-06-14 | 2025-05-09 | Ｐｄ－１に対する抗体およびその使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025078387A Pending JP2025121997A (ja) | 2019-06-14 | 2025-05-09 | Ｐｄ－１に対する抗体およびその使用方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20220249640A1 (https=) |
| EP (1) | EP3983444A4 (https=) |
| JP (2) | JP7680968B2 (https=) |
| AU (1) | AU2020291946A1 (https=) |
| CA (1) | CA3141927A1 (https=) |
| WO (1) | WO2020252478A2 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7769007B2 (ja) * | 2020-12-23 | 2025-11-12 | イミュノウェイク インコーポレイテッド | イムノサイトカイン及びその使用 |
| IL305758A (en) * | 2021-03-10 | 2023-11-01 | Immunowake Inc | Immunomodulatory compounds and their uses |
| CA3235894A1 (en) * | 2021-10-25 | 2023-05-04 | Brile Chung | Compositions and methods for therapeutic delivery |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101899114A (zh) * | 2002-12-23 | 2010-12-01 | 惠氏公司 | 抗pd-1抗体及其用途 |
| EP1702069A2 (en) * | 2004-01-05 | 2006-09-20 | EMD Lexigen Research Center Corp. | Interleukin-12 targeted to oncofoetal fibronectin |
| JP5307708B2 (ja) * | 2006-06-02 | 2013-10-02 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | ヒトｉｌ−６受容体に対する高親和性抗体 |
| WO2010041060A1 (en) * | 2008-10-08 | 2010-04-15 | Medimmune Limited | Targeted binding agents directed to heparanase and uses thereof 463 |
| EP2766035B1 (en) * | 2011-10-11 | 2018-03-28 | Universität Zürich Prorektorat MNW | Combination medicament comprising il-12 and an agent for blockade of t-cell inhibitory molecules for tumour therapy |
| CN108250303B (zh) | 2016-12-19 | 2023-01-03 | 南京金斯瑞生物科技有限公司 | 单域抗体融合蛋白及其应用 |
| KR102746901B1 (ko) * | 2017-03-03 | 2024-12-26 | 옵시디안 테라퓨틱스, 인크. | Cd19 조성물 및 면역요법을 위한 방법 |
| CA3059542A1 (en) * | 2017-04-12 | 2018-10-18 | Pfizer Inc. | Antibodies having conditional affinity and methods of use thereof |
| CN109422815A (zh) * | 2017-08-28 | 2019-03-05 | 复旦大学 | 双特异性嵌合抗原受体c-Met/PD-1 scFv-CAR-T及其构建方法和应用 |
| CA3119644A1 (en) * | 2018-11-30 | 2020-06-04 | Dana-Farber Cancer Institute, Inc. | Chimeric antigen receptor factories and methods of use thereof |
-
2020
- 2020-06-15 EP EP20823045.8A patent/EP3983444A4/en active Pending
- 2020-06-15 AU AU2020291946A patent/AU2020291946A1/en active Pending
- 2020-06-15 CA CA3141927A patent/CA3141927A1/en active Pending
- 2020-06-15 JP JP2021573799A patent/JP7680968B2/ja active Active
- 2020-06-15 WO PCT/US2020/037791 patent/WO2020252478A2/en not_active Ceased
- 2020-06-15 US US17/618,361 patent/US20220249640A1/en active Pending
-
2025
- 2025-05-09 JP JP2025078387A patent/JP2025121997A/ja active Pending